Evidence map›Paper›PMID 25825675›Full record

ArticleJournal of pharmaceutical policy and practice2015

Medicines and universal health coverage: challenges and opportunities.

Maryam Bigdeli, Richard Laing, Göran Tomson, Zaheer-Ud-Din Babar

Abstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Challenges to Achieving Universal Health Coverage Throughout the World: A Systematic Review.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2022
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Drug shops for stronger health systems: learning from initiatives in six LMICs.Journal of pharmaceutical policy and practice · 2021
    Review
  18. Acceptability of a Prime Vendor System in Public Healthcare Facilities in Tanzania.International journal of health policy and management · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maryam BigdeliAlliance for Health Policy and Systems Research, World Health Organization, 20 Avenue Appia, CH-1211 Geneva 27, Switzerland.
Richard LaingBoston University School of Public Health, 801 Massachusetts Avenue, Boston, MA 02118 USA.
Göran TomsonDepartment of Learning Informatics Management Ethics and Public Health Sciences, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
Zaheer-Ud-Din BabarSchool of Pharmacy, University of Auckland, Private Mail Bag 92019 Auckland, New Zealand.

Funding

World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID25825675
PMCPMC4350289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.